Skip to main content
. 2010 Jan;69(1):74–84. doi: 10.1111/j.1365-2125.2009.03547.x

Table 4.

Characteristics of Patients with coronary artery disease and their matched controls by level of adherence after 1 year's follow-up

Cases occurring after 1 year of follow-up and their controls
Cases among low adherence Controls among low adherence Cases among high adherence Controls among high adherence
Numbers 1396 18 707 5616 85 462
Age (continuous) (years) 67 (±10) 67 (±10) 67 (±9) 67 (±9)
Sex (% male) 43 37 39 33
Social assistance (%) 13 12 11 9
Cerebrovascular disease during follow-up (%)§ 4 2 4 2
Chronic heart failure during follow-up (%) 4 2 3 1
Peripheral arterial disease during follow-up (%)†† 3 1 3 2
Other cardiovascular events during follow-up (%)‡‡ 16 8 17 7
Having ≥2 cardiovascular events (%) 10 2 9 2
Diabetes (%)§§ 19 15 20 16
Diagnosed and nontreated (%)§§ 6 6 7 6
Newly treated for diabetes mellitus (%)§§ 2 2 2 1
Antidiabetic agents adherence <80% (%)§§¶¶ 6 4 2 2
Antidiabetic agent adherence ≥80% (%)§§¶¶ 5 3 9 7
Dyslipidaemia (%)§§ 38 31 40 35
Diagnosed and nontreated (%)§§ 4 4 4 4
New treated for dyslipidaemia (%)§§ 7 4 8 5
Lipid-lowering agent adherence <80% (%)§§¶¶ 17 14 7 6
Lipid-lowering agent adherence ≥80% (%)§§¶¶ 10 9 21 20
Respiratory diseases (%)§§ 26 18 24 17
Antidepressant drugs (%)§§ 16 12 15 12
Anxiolytic drugs (%)§§ 43 36 42 36
Chronic disease score (≥4) (%) 15 10 14 10

At treatment initiation.

§

Diagnosis of cerebrovascular disease (ICD-9 codes 430-438) or medical procedures.

Diagnosis of chronic heart failure (ICD-9 codes 398.91, 402.01, 402.11, 402.91, 428.0, 428.1 and 428.9) or a prescription of furosemide alone or with digoxin, angiotensin converting enzyme inhibitor, spironolactone or β-blockers.

††

Diagnosis of peripheral arterial disease: diagnosis (ICD-9 codes 440-447, medical procedure of noncoronary angioplasty, or use of pentoxifylline).

‡‡

Diagnosis of other cardiovascular disease: arrhythmia: diagnosis (ICD-9 code 427), a medical procedure using a pacemaker and the use of drugs for cardiac arrhythmias (amiodarone, digoxin, quinidine, disopyramide, flecainamide, mexiletine, procainamide, propafenone, or sotalol); or valvular heart disease; or anticoagulants; other cardiopathy.

§§

ICD-9 or pharmacological treatment.

¶¶

Proportion of days covered (%) in the year before the index date.